StageZero to Issue Q2 2021 Financial Results and Hold Conference Call on Tuesday, August 17

Biotech & MedTech

August 11, 2021 (Source) — StageZero Life Sciences (“StageZero” or the “Company”) (TSX:SZLS) today announced that it will release its second quarter 2021 operational results before the market open on Tuesday, August 17, 2021. StageZero’s Chairman and CEO, James Howard-Tripp, will host a conference call and accompanying webcast at 8:30 a.m. EST on Tuesday, August 17, 2021, to review the operational results and discuss business developments.

Analyst and Investor Call

Event Date: Tuesday, August 17, 2021
Time: 8:30 a.m. EST
Webcast Link
Participant Numbers: Toll Free: +1 844-602-0380

International: +1-862-298-0970
Replay Number: Toll Free: +1-877-481-4010

International: +1-919-882-2331
Replay Passcode: 42373

About StageZero Life Sciences Ltd.
StageZero Life Sciences is dedicated to the early detection of multiple diseases through whole blood tests. The Company’s next-generation test, Aristotle®, is the first-ever multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. StageZero’s full service, telehealth platform includes access to physicians and phlebotomists who can prescribe and draw samples for individuals and groups, and the Company operates a CAP accredited and CLIA certified high-complexity reference laboratory in Richmond, Virginia. In addition, leveraging its specialty in polymerase chain reaction (PCR) testing for the early identification of cancer through blood, StageZero also provides both COVID PCR testing (swab and saliva) and blood test analysis (Antibody testing). For more information, please visit

James Howard-Tripp
Chairman & CEO

For further information please contact:
Rebecca Greco

Investor Relations
Tel: 1-855-420-7140 ext. 1838
[email protected]

SOURCE: StageZero Life Sciences Ltd